Holdings of Global X Genomics & Biotechnology ETF
GLOBAL X FUNDS · Original filing · Compare with another fund · Report an error
- Net assets
- 52.4M $ including 52.4M $ in equities, 100.0 %
- Positions
- 50 in 8 countries
- Top ten
- 49.8 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Moderna Inc | 76,841 | 4.1M $ | 7.86 % |
| 2 | Praxis Precision Medicines Inc | 9,697 | 3.3M $ | 6.23 % |
| 3 | Arrowhead Pharmaceuticals Inc | 47,107 | 3M $ | 5.69 % |
| 4 | Illumina Inc | 19,973 | 2.7M $ | 5.13 % |
| 5 | Guardant Health Inc | 26,261 | 2.5M $ | 4.71 % |
| 6 | Vertex Pharmaceuticals Inc | 4,551 | 2.3M $ | 4.32 % |
| 7 | BioMarin Pharmaceutical Inc | 36,598 | 2.3M $ | 4.31 % |
| 8 | Natera Inc | 9,843 | 2M $ | 3.91 % |
| 9 | BioNTech SE | 18,367 | 2M $ | 3.87 % |
| 10 | AVIDITY BIOSCIENCES INC | 27,249 | 2M $ | 3.75 % |
| 11 | QIAGEN NV | 38,211 | 1.9M $ | 3.63 % |
| 12 | CRISPR Therapeutics AG | 30,338 | 1.8M $ | 3.48 % |
| 13 | Bio-Techne Corp | 30,603 | 1.8M $ | 3.45 % |
| 14 | Bristol-Myers Squibb Co | 22,278 | 1.4M $ | 2.65 % |
| 15 | Alnylam Pharmaceuticals Inc | 3,941 | 1.3M $ | 2.51 % |
| 16 | Veracyte Inc | 34,212 | 1.3M $ | 2.39 % |
| 17 | Eli Lilly & Co | 1,165 | 1.2M $ | 2.34 % |
| 18 | Twist Bioscience Corp | 25,637 | 1.2M $ | 2.30 % |
| 19 | Gilead Sciences Inc | 8,009 | 1.2M $ | 2.28 % |
| 20 | AstraZeneca PLC | 5,706 | 1.2M $ | 2.28 % |
| 21 | Beam Therapeutics Inc | 40,627 | 1.2M $ | 2.21 % |
| 22 | 10X Genomics Inc | 49,124 | 1.1M $ | 2.16 % |
| 23 | LEGEND BIOTECH CORP | 59,071 | 1.1M $ | 2.14 % |
| 24 | Ultragenyx Pharmaceutical Inc | 39,779 | 930.4K $ | 1.78 % |
| 25 | GeneDx Holdings Corp | 11,270 | 898.3K $ | 1.72 % |
| 26 | WaVe Life Sciences Ltd | 56,445 | 786.3K $ | 1.50 % |
| 27 | Genscript Biotech Corp | 498,918 | 761.6K $ | 1.45 % |
| 28 | Sarepta Therapeutics Inc | 40,976 | 686.8K $ | 1.31 % |
| 29 | Intellia Therapeutics Inc | 45,069 | 621.1K $ | 1.19 % |
| 30 | CareDx Inc | 22,308 | 418.5K $ | 0.80 % |
| 31 | uniQure NV | 24,242 | 378.9K $ | 0.72 % |
| 32 | Vir Biotechnology Inc | 40,138 | 364.9K $ | 0.70 % |
| 33 | Personalis Inc | 23,562 | 213.5K $ | 0.41 % |
| 34 | Pacific Biosciences of California Inc | 119,496 | 200.8K $ | 0.38 % |
| 35 | Agilent Technologies Inc | 1,653 | 200.6K $ | 0.38 % |
| 36 | Rocket Pharmaceuticals Inc | 37,567 | 188.2K $ | 0.36 % |
| 37 | Prime Medicine Inc | 40,671 | 187.9K $ | 0.36 % |
| 38 | REGENXBIO Inc | 20,483 | 185.2K $ | 0.35 % |
| 39 | Myriad Genetics Inc | 39,242 | 180.9K $ | 0.35 % |
| 40 | Mesa Laboratories Inc | 1,851 | 178.8K $ | 0.34 % |
| 41 | Maravai LifeSciences Holdings Inc | 46,674 | 166.2K $ | 0.32 % |
| 42 | Stoke Therapeutics Inc | 4,522 | 164.6K $ | 0.31 % |
| 43 | Standard BioTools Inc | 119,323 | 134.8K $ | 0.26 % |
| 44 | Fulgent Genetics Inc | 8,763 | 134.3K $ | 0.26 % |
| 45 | Arcturus Therapeutics Holdings Inc | 15,040 | 123.8K $ | 0.24 % |
| 46 | Caribou Biosciences Inc | 59,913 | 113.8K $ | 0.22 % |
| 47 | Sana Biotechnology Inc | 26,441 | 111.3K $ | 0.21 % |
| 48 | Sangamo Therapeutics Inc | 244,820 | 105.8K $ | 0.20 % |
| 49 | Editas Medicine Inc | 46,709 | 102.8K $ | 0.20 % |
| 50 | Atrium Therapeutics Inc | 2,725 | 40.2K $ | 0.08 % |
Sector breakdown
- Health care 33.7 %
- Unattributed 66.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 96.3 %
- GBP 2.3 %
- HKD 1.5 %
The quoted currency of each line, as declared.
Country breakdown
- United States 84.5 %
- Germany 3.9 %
- Switzerland 3.5 %
- United Kingdom 2.3 %
- Cayman Islands 2.1 %
- Singapore 1.5 %
- Hong Kong SAR China 1.5 %
- Netherlands 0.7 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 43 | 44.3M $ | 84.55 % |
| 2 | Germany | 1 | 2M $ | 3.87 % |
| 3 | Switzerland | 1 | 1.8M $ | 3.48 % |
| 4 | United Kingdom | 1 | 1.2M $ | 2.28 % |
| 5 | Cayman Islands | 1 | 1.1M $ | 2.14 % |
| 6 | Singapore | 1 | 786.3K $ | 1.50 % |
| 7 | Hong Kong SAR China | 1 | 761.6K $ | 1.45 % |
| 8 | Netherlands | 1 | 378.9K $ | 0.72 % |
Cite this page
Titelia. "Holdings of Global X Genomics & Biotechnology ETF". https://titelia.com/en/funds/S000062676